COLITATE 2MIU
Colistimethate Sodium Injection 2 MIU
A Critical Solution Against Multidrug-Resistant Gram-Negative Infections
Colistimethate Sodium Injection 2 MIU is a high-potency, last-resort antibiotic designed to combat severe infections caused by multidrug-resistant (MDR) Gram-negative pathogens. As antimicrobial resistance continues to rise, Colistimethate remains a cornerstone therapy in intensive care and hospital settings.
Key Features:
Broad-Spectrum Gram-Negative Coverage: Highly effective against Pseudomonas aeruginosa, Acinetobacter baumannii, and Klebsiella pneumoniae – even those resistant to carbapenems.
High-Potency Dosage: Each 2 MIU vial offers a powerful dose for flexible, weight- and severity-based dosing strategies.
Trusted in Critical Care: Frequently used in ICU settings for serious infections like VAP, sepsis, and complicated UTIs.
Essential for Stewardship Programs: A valuable agent in preserving antibiotic efficacy and combating resistance.
Brand Name | COLITATE 2MIU |
---|---|
Composition | Colistimethate 2MIU |
MRP | ₹2850 |
Packing | Tubular Vial+Tray with cover |